Mumbai-based pharmaceutical major Cipla has reported its financial results for the April-June period, with a ...

Mumbai: Cipla started FY26 on a strong note with a 4 percent year-on-year (YoY) rise in income from operations at Rs 6,957 ...

The Atal Pension Yojana (APY) has achieved a significant milestone by surpassing 8 crore total gross enrollments with an ...

India's auto sector is set for muted 6–7% growth in FY26, says Motilal Oswal. Two-wheelers and small cars face sharp volume ...

GMDC's profit margins squeezed by declining income from mining and power operations, reporting a 11% y-o-y drop in profit.

Laurus Lab ’s net profit increased manifold to ₹163 crore in the first quarter of the current fiscal ended June 30, 2025 ...

Sobha has announced a significant surge in its financial performance. The company's net consolidated profit witnessed a ...

The brokerage said that the industry may remain in a cautious phase in the near term, with a rebound largely dependent on ...

Atal Pension Yojana (APY), a key social security initiative for unorganised sector workers, has exceeded 8 crore enrolments, ...

Cipla Q1 FY26 Results Preview, Pharma Stock Price vs Nifty 50: Cipla shares are trading with cautious gains with investors ...

Mahindra Lifespace Developers achieves a remarkable net profit of ₹51.26 crore in Q1 FY26, up from ₹12.74 crore in the ...

Amid an ongoing global economic slowdown, India is poised to maintain strong growth momentum, with the economy projected to ...